LC

Lynne Chou O’Keefe

Founder and Managing Partner at Define Ventures

United States

Investor
VC
Founder

Invests in

Stages:

Seed
Series A

  • Min Investment:

    $750,000.00

  • Max Investment:

    $6,000,000.00

  • Target Investment:

    $4,000,000.00

Skills

Corporate Development
Cross-functional Team Leadership
Global Marketing
Investment Banking
Lifesciences
Medical Devices
Marketing
Mergers
Product Launch
Strategy
Vascular
Venture Capital

Education

Lists including Lynne

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

9amHealth

Seed

Total Funding: $30M

Cohere Health

Series A

Total Funding: $96M

DexCare

Series A

Total Funding: $150M

Intrinsic

Series A

Total Funding: $130M

Crescendo Health

Seed

Total Funding: $3M

UpStream Care

Series B

Total Funding: $140M

Folx Health

Seed

Total Funding: $59M

Soda Health

Seed

Total Funding: $31M

Concert Health

Series B

Total Funding: $59M

Waltz Health

Series A

Total Funding: $35M

Lightship

Series A

Total Funding: $120M

Story Health

Seed

Total Funding: $4M

MedArrive

Seed

Total Funding: $30M

Livongo

Series B

Total Funding: $240M

Work Experience

DV
Define Ventures

2018

  • Founder and Managing Partner

    2018

    Early Stage Digital Health VC partnering with entrepreneurs at Seed, Series A, and Series B that are defining healthcare for the future.

KP
Kleiner Perkins Caufield & Byers

2013 - 2018

  • Partner, Life Sciences Group

    2013 - 2018

Abbott Vascular/Guidant

2005 - 2013

  • Global Product Marketing

    2005 - 2013

AP
Apax Partners

2001 - 2003

  • Venture Capital, Enterprise Software

    2001 - 2003

GS
Goldman Sachs

1999 - 2001

  • Investment Banking, Mergers and Acquisitions

    1999 - 2001